Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.
暂无分享,去创建一个
A. Regev | K. Shekhar | S. Orkin | L. Dohnalová | E. Elinav | Alper Kucukural | S. Beyaz | Haiwei Mou | Pawan Kumar | J. Fox | M. Biton | Eider Valle-Encinas | C. Thaiss | Ömer H. Yilmaz | Christoph A. Thaiss | M. Fein | J. Roper | A. Erdemir | J. McAleer | Onur Eskiocak | Brian Yueh | Mohammad Almeqdadi | Aybuke Alici-Garipcan | Karoline Dogum | C. Chung | Khristian E. Bauer-Rowe | Michael E Xifaras | Damodaran Annamalai | H. Meyer | Ilgin Ergin | D. M. Özata | Vyom Shah | Katherine Papciak | Kadir Ozler | Moshe Biton | J. Fox | Semir Beyaz | Deniz M. Özata
[1] S. Beyaz,et al. High-fat diet activates a PPAR-δ program to enhance intestinal stem cell function. , 2021, Cell stem cell.
[2] S. Itzkovitz,et al. Diet Diurnally Regulates Small Intestinal Microbiome-Epithelial-Immune Homeostasis and Enteritis , 2020, Cell.
[3] A. Shalek,et al. Distribution and storage of inflammatory memory in barrier tissues , 2020, Nature Reviews Immunology.
[4] N. Waddell,et al. MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. , 2019, Immunity.
[5] Kenny Q. Ye,et al. The nutritional environment determines which and how intestinal stem cells contribute to homeostasis and tumorigenesis. , 2019, Carcinogenesis.
[6] Onur Yukselen,et al. DolphinNext: a distributed data processing platform for high throughput genomics , 2019, BMC Genomics.
[7] H. Clevers,et al. T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation. , 2019, Immunity.
[8] R. Evans,et al. FXR Regulates Intestinal Cancer Stem Cell Proliferation , 2019, Cell.
[9] J. Luke,et al. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers , 2019, Clinical Cancer Research.
[10] Ramnik J. Xavier,et al. T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation , 2018, Cell.
[11] E. Fuchs,et al. Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease , 2018, Cell.
[12] Stephanie A. Bien,et al. Discovery of common and rare genetic risk variants for colorectal cancer , 2018, Nature Genetics.
[13] G. Barton,et al. A Map of Toll‐like Receptor Expression in the Intestinal Epithelium Reveals Distinct Spatial, Cell Type‐Specific, and Temporal Patterns , 2018, Immunity.
[14] Onur Yukselen,et al. DEBrowser: interactive differential expression analysis and visualization tool for count data , 2018, bioRxiv.
[15] Benjamin J. Raphael,et al. Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer , 2018, Systems Immuno-Oncology.
[16] R. Sachidanandam,et al. Quiescent Tissue Stem Cells Evade Immune Surveillance , 2018, Immunity.
[17] D. Ford,et al. Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis. , 2018, Cell stem cell.
[18] J. Clohessy,et al. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer , 2018, Nature Genetics.
[19] Adam Akkad,et al. Colonoscopy-based colorectal cancer modeling in mice with CRISPR–Cas9 genome editing and organoid transplantation , 2018, Nature Protocols.
[20] David A. Drew,et al. Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor. , 2017, Gastroenterology.
[21] Nir Hacohen,et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation , 2017, Nature Communications.
[22] E. Fuchs,et al. Inflammatory Memory Sensitizes Skin Epithelial Stem Cells to Tissue Damage , 2017, Nature.
[23] H. Lee,et al. Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling , 2017, PloS one.
[24] S. Rosenberg,et al. Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] W. Willett,et al. Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] L. Zitvogel,et al. Nutrition, inflammation and cancer , 2017, Nature Immunology.
[27] G. Victora,et al. Intestinal Epithelial and Intraepithelial T Cell Crosstalk Mediates a Dynamic Response to Infection , 2017, Cell.
[28] Camille Stephan-Otto Attolini,et al. Mex3a Marks a Slowly Dividing Subpopulation of Lgr5+ Intestinal Stem Cells. , 2017, Cell stem cell.
[29] F. Nestle,et al. Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation , 2017, Cell.
[30] Francisco J. Sánchez-Rivera,et al. In vivo genome editing and organoid transplantation models of colorectal cancer , 2017, Nature Biotechnology.
[31] Takashi Saito,et al. CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function , 2017, Front. Immunol..
[32] Sean C. Bendall,et al. Systemic Immunity Is Required for Effective Cancer Immunotherapy , 2017, Cell.
[33] D. Vetrie,et al. CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. , 2017, Blood.
[34] Camille Stephan-Otto Attolini,et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.
[35] S. Orkin,et al. The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells , 2016, Nature Immunology.
[36] Eran Segal,et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain , 2016, Nature.
[37] S. Beyaz,et al. Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway , 2016, Clinical Cancer Research.
[38] W. Wahli,et al. High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine , 2016, Proceedings of the National Academy of Sciences.
[39] Evan Z. Macosko,et al. Comprehensive Classification of Retinal Bipolar Neurons by Single-Cell Transcriptomics , 2016, Cell.
[40] B. Bogen,et al. Idiotype-specific CD4+ T cells eradicate disseminated myeloma , 2016, Leukemia.
[41] Dudley Lamming,et al. High fat diet enhances stemness and tumorigenicity of intestinal progenitors , 2016, Nature.
[42] M. Karin,et al. Obesity and Cancer: The Oil that Feeds the Flame. , 2016, Cell metabolism.
[43] R. Jenq,et al. Interleukin-22 Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration , 2015, Nature.
[44] P. Linsley,et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.
[45] Derek LeRoith,et al. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. , 2015, Physiological reviews.
[46] J. Castle,et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer , 2015, Nature.
[47] J. Olefsky,et al. High Fat Diet Causes Depletion of Intestinal Eosinophils Associated with Intestinal Permeability , 2015, PloS one.
[48] L. Hooper,et al. Antimicrobial defense of the intestine. , 2015, Immunity.
[49] N. Warner,et al. NOD1 and NOD2: signaling, host defense, and inflammatory disease. , 2014, Immunity.
[50] B. Verrier,et al. Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity , 2014, The Journal of Immunology.
[51] S. Moossavi,et al. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease , 2014, Clinical and experimental immunology.
[52] Shawn W. Polson,et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity , 2014, Nature.
[53] S. Rosenberg,et al. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer , 2014, Science.
[54] Y. Belkaid,et al. Role of the Microbiota in Immunity and Inflammation , 2014, Cell.
[55] W. Reith,et al. Interferon-γ Induces Expression of MHC Class II on Intestinal Epithelial Cells and Protects Mice from Colitis , 2014, PloS one.
[56] T. Fehr,et al. Allospecific Rejection of MHC Class I‐Deficient Bone Marrow by CD8 T Cells , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[57] Åsa K. Björklund,et al. Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.
[58] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[59] H. Waldmann,et al. Secreted and Transmembrane 1A Is a Novel Co-Stimulatory Ligand , 2013, PloS one.
[60] H. Clevers. The Intestinal Crypt, A Prototype Stem Cell Compartment , 2013, Cell.
[61] C. Sweeney,et al. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. , 2013, Journal of the National Cancer Institute.
[62] J. Wolchok,et al. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype , 2012, The Journal of experimental medicine.
[63] Charlotte E. Egan,et al. Toll-like Receptor 4 Is Expressed on Intestinal Stem Cells and Regulates Their Proliferation and Apoptosis via the p53 Up-regulated Modulator of Apoptosis* , 2012, The Journal of Biological Chemistry.
[64] Hans Clevers,et al. Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.
[65] A. Macpherson,et al. Interactions Between the Microbiota and the Immune System , 2012, Science.
[66] Dudley Lamming,et al. mTORC1 in the Paneth cell niche couples intestinal stem cell function to calorie intake , 2012, Nature.
[67] G. Dranoff,et al. Combining immunotherapy and targeted therapies in cancer treatment , 2012, Nature Reviews Cancer.
[68] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[69] Erin M. Coffee,et al. The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer , 2011, PloS one.
[70] P. J. van den Elsen. Expression Regulation of Major Histocompatibility Complex Class I and Class II Encoding Genes , 2011, Frontiers in immunology.
[71] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[72] K. Basen-Engquist,et al. Obesity and Cancer Risk: Recent Review and Evidence , 2011, Current oncology reports.
[73] B. Druker,et al. CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. , 2010, Blood.
[74] P. Muranski,et al. Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma , 2010, The Journal of experimental medicine.
[75] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[76] Maria T. Abreu,et al. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function , 2010, Nature Reviews Immunology.
[77] S. Zhang,et al. The role of CD4 T cell help for CD8 CTL activation. , 2009, Biochemical and biophysical research communications.
[78] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[79] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[80] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[81] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[82] A. Gruber,et al. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells , 2008, Gut.
[83] G. Corner,et al. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. , 2008, Cancer research.
[84] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[85] S. Dahan,et al. Epithelia: lymphocyte interactions in the gut , 2007, Immunological reviews.
[86] F. Bäckhed,et al. Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[87] M. Giovannini,et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers , 2004, Laboratory Investigation.
[88] A. Cocchiarella,et al. Intact Gram-Negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus Bacteria Activate Innate Immunity via Toll-Like Receptor 2 but Not Toll-Like Receptor 4 , 2004, Infection and Immunity.
[89] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[90] L. Staudt,et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. , 2004, Blood.
[91] A. Kettunen,et al. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer. , 2003, Cancer research.
[92] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[93] R. Lothe,et al. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis , 2002, British Journal of Cancer.
[94] Rong Wang,et al. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. , 2001, Trends in immunology.
[95] J. Allison,et al. ICOS co-stimulatory receptor is essential for T-cell activation and function , 2001, Nature.
[96] S. Carding,et al. Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states. , 2000, Gastroenterology.
[97] C. Lowenstein,et al. The Central Role of CD4+ T Cells in the Antitumor Immune Response , 1998, The Journal of experimental medicine.
[98] R. Hershberg,et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. , 1997, The Journal of clinical investigation.
[99] W. Fiers,et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[100] A. Quaroni,et al. Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. , 1984, Journal of immunology.
[101] D. Coleman. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice , 1978, Diabetologia.
[102] K. Ozato,et al. Regulation of major histocompatibility complex class I genes. , 1989, The Year in immunology.
[103] G. Wong,et al. Inducible expression of H–2 and Ia antigens on brain cells , 1984, Nature.